Health‑IT executives are bracing for a dip in capital spending through 2027, yet AI‑driven clinical tools and patient‑experience initiatives are climbing to the top of C‑suite agendas, according to a new Sage Growth Partners study.
A cautious outlook on capital spending
Sage Growth Partners surveyed 101 senior leaders from health systems and hospitals, asking how they expect capital allocations to shift over the next two years. The findings paint a stark picture: 41 % of respondents anticipate a reduction in capital investments for 2026‑27, while 19 % forecast no change and only 5 % see a 20 % increase. Those numbers mark a noticeable retreat from the growth‑focused budgets of previous years.
The decline is not uniform across all spend categories. Funding for new markets or revenue‑stream initiatives is now a high priority for 46 % of executives, up from 34 % in 2023. This suggests that while overall capital may be constrained, leaders are still willing to back projects that promise fresh growth avenues.
“As health systems and hospitals grapple with declining capital investments, C‑suite leaders are likely to apply greater degrees of scrutiny to health‑IT purchasing decisions,” said Dan D’Orazio, CEO of Sage Growth Partners. “Overall, capital planning is shifting toward initiatives that drive growth, such as acquiring and retaining patients, expanding into new markets, and diversifying revenue streams to increase top‑line revenue.”
AI climbs to the top of technology priorities
AI‑based clinical solutions now rank as the top technology initiative for 57 % of surveyed C‑suite leaders for the next two years, a dramatic jump from 19 % in 2023. Meanwhile, AI‑driven administrative tools have moved from a niche concern to 29 % of executives listing them among their top five technology priorities, up from 6 % a year earlier.
These figures indicate that health‑IT vendors offering AI‑enhanced diagnostic, predictive, or workflow‑optimization capabilities may find a more receptive market, even as overall capital pools shrink. The data also underscores a broader trend: hospitals are looking to AI not just for cost savings but for tangible improvements in clinical outcomes and operational efficiency.
Patient experience becomes the flagship strategic initiative
Beyond technology, the report highlights a strategic pivot toward the end‑user. Patient experience now sits at the apex of C‑suite strategic initiatives for the coming two years. Executives are keen to integrate virtual‑care platforms, digital health tools, and engagement technologies into existing care models, hoping to boost satisfaction, loyalty, and ultimately, revenue.
The emphasis on patient experience dovetails with the 40 % of leaders who identified patient acquisition as a top priority and the same 40 % who are investing in patient‑engagement technologies. In practice, this could translate into accelerated rollout of telehealth portals, personalized communication suites, and data‑driven outreach programs designed to keep patients within a health system’s ecosystem.
What the findings mean for health‑IT vendors
- ROI‑centric selling: CFOs will demand clear, quantifiable returns on any health‑IT purchase. Vendors must be prepared with robust business‑case models that illustrate cost avoidance, revenue uplift, or efficiency gains tied to AI deployments.
- Pricing model flexibility: As organizations scrutinize spend, they may gravitate toward subscription‑based or outcome‑based pricing structures that align vendor revenue with performance metrics.
- Strategic alignment: Solutions that can be positioned as enablers of new revenue streams—whether through virtual‑care expansion, AI‑enhanced diagnostics, or patient‑engagement platforms—are likely to receive preferential funding.
- Integration readiness: With patient experience at the forefront, vendors that offer interoperable APIs and seamless integration with existing EMR/EHR ecosystems will have a competitive edge.
“Ultimately, C‑suites are looking to health‑IT companies to demonstrate cost‑savings to CFOs focused on driving ROI, and to help CIOs align digital strategies with organizational performance and financial goals,” said Stephanie Kovalick, Chief Strategy Officer at Sage Growth Partners.
Key takeaways from the Sage Growth Partners report
- Capital constraints are real: Over 40 % of health‑system leaders expect reduced capital spending in the 2026‑27 window.
- AI is no longer optional: AI‑based clinical solutions dominate technology roadmaps, with administrative AI gaining traction.
- Patient‑experience drives strategy: Executives are prioritizing initiatives that improve how patients interact with and perceive care delivery.
- Revenue‑generation focus: Funding for new markets and patient acquisition remains a high priority, indicating a shift toward growth‑oriented capital allocation.
- Vendors must adapt: Clear ROI, flexible pricing, and integration capabilities will be decisive factors in winning health‑IT contracts under tighter budgets.
- Patient acquisition initiatives highlight the marketing aspect of growth strategies.
- Aligning solutions with overall strategic initiative goals is essential for budget approval.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
